Summary of Life Technologies Corporation v. Promega Corporation

The United States Supreme Court has come out with a controversial patent decision on February 22, 2017, limiting the scope of protection for U.S. patents. Life Technologies Corporation v. Promega Corporation, dealt with an international intersection supply chain and a patent. The science behind the patent is extremely complicated, but essentially the issue of the case was whether a single enzyme that was supplied to a facility in the U.K., which was a component that made up the DNA test kit, infringed the patent. The majority opinion, which was given by Justice Sonia Sotomayor, stated that shipping a single component that makes up a patent is not enough to constitute infringement. Continue reading “Summary of Life Technologies Corporation v. Promega Corporation”

Introduction to European Patents and European Patents with Unitary Effect

A patent is a property right wherein a set of exclusive rights are granted for a limited time.[1] Intellectual Property laws are generally domestic, thus, anyone who files a patent within their country is not protected across national boundaries. In order to resolve this issue and to protect their nationals, several international treaties have been adopted to protect inventors most notably: the Paris Convention, Patent Co-operation Treaty, Patent Law Treaty, and the European Patent Convention. Continue reading “Introduction to European Patents and European Patents with Unitary Effect”